Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ligand. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel quinoline-substituted bisoxazoline ligand enables high enantioselectivity in trifluoromethylation. Offers scalable synthesis and cost-effective supply chain solutions for pharmaceutical intermediates.
Patent CN116041393B reveals a novel N-N axis chiral bis-indole phosphine ligand synthesis offering superior stereoselectivity and cost-effective manufacturing for pharmaceutical intermediates.
Novel axial chiral phosphine catalyst synthesis via chiral phosphoric acid. High ee, mild conditions. Ideal for asymmetric hydrosilylation and coupling. Reliable supplier for pharma intermediates.
Patent CN110724164B details novel pyridine-substituted spiro ligands enabling high TON hydrogenation. Ideal for API intermediates.
Patent CN101717408B introduces a bis-phosphorus ylide ligand enabling high-yield alpha-arylation. This breakthrough offers significant cost reduction in API manufacturing and robust supply chain reliability.
Patent CN112126941B introduces a green electrochemical method for synthesizing polysubstituted 10-hydroxyphenanthrene derivatives, offering cost reduction and high purity for pharmaceutical intermediates.
Patent CN106478720B details a metal-free oxazoline catalyst enabling high-purity pharmaceutical intermediates with reduced environmental impact and scalable production capabilities.
Patent CN111217847A discloses stable thiosilane ligands for iridium-catalyzed borylation, offering superior yield and simplified purification for reliable pharmaceutical intermediate suppliers.
Patent CN111233852A discloses a benzoisofuran-based ligand for asymmetric fluorination, offering mild conditions and high stereoselectivity for pharmaceutical intermediate manufacturing.
Patent CN102924206B details a ligand-free aqueous synthesis for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN101591250A details a streamlined one-step Mannich synthesis and tartaric acid resolution for high-purity chiral amino alcohol ligands, offering significant cost and supply chain advantages.
Advanced Heck coupling method for rigid bipyridine ligands. High-yield synthesis reduces costs in optoelectronic material manufacturing with scalable processes.
Patent CN111925356B details a novel chiral quinoline-imidazoline ligand enabling high-yield nickel-catalyzed synthesis of chiral lactams for pharmaceutical intermediates.
Patent CN110724164B discloses novel 3-substituted spiro ligands achieving 99% ee. Enables cost-effective API intermediate manufacturing with high TON.
Discover the novel N-N axis chiral bis-indole phosphine ligand from patent CN116041393B. Offers superior stereoselectivity for asymmetric catalysis and cost-effective manufacturing.
Novel N-N axis chiral ligand synthesis via organocatalysis. High enantioselectivity for pharma intermediates. Cost-effective scalable route for complex molecule manufacturing.
Novel biaryl ligand synthesis via Catellani reaction offers high enantioselectivity and scalable routes for pharmaceutical intermediates.
Patent CN111718372B discloses a novel axial chiral ligand enabling high-yield asymmetric allylic substitution with simplified synthesis for cost-effective API manufacturing.
Patent CN114057717B reveals novel ligand synthesis enhancing enantioselectivity. Delivers substantial cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN116715699B reveals manganese-based asymmetric hydrogenation. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.